Medicine recalls
|
| |
| Batch recall of Apo-Mometasone Aqueous Nasal Spray 50mcg/metered spray |
| |
The Department of Health (DH) today (February 16) endorsed a licensed drug wholesaler, Hind Wing Co Ltd (Hind Wing), to recall a batch (batch number: TX5343) of Apo-Mometasone Aqueous Nasal Spray 50mcg/metered spray (HK-62898) from the market as a precautionary measure due to potential quality issue.
The DH received notification from Hind Wing today that the overseas manufacturer of the product is initiating a voluntary recall of the above batch due to potential presence of Burkholderia cepacia complex. As a precautionary measure, Hind Wing is voluntarily recalling the affected batch from the market.
The above product, containing mometasone furoate, is a prescription medicine indicated for the prophylaxis and treatment of allergic rhinitis. According to Hind Wing, the above batch of product has been imported into Hong Kong and supplied to the Hospital Authority, private hospitals, private doctors and pharmacies.
Hind Wing has set up a hotline (2541 5731) to answer related enquiries.
So far, the DH has not received any adverse reaction reports in connection with the affected batch of product. The DH will closely monitor the recall.
Members of the public should consult healthcare professionals if in doubt or feeling unwell after using the product.
Ends/Friday, 16 Feb 2024
|
| |
|
